Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilcox

Showing results (61-70 of 454) with videos related to

Pageof 46
Sort By:
British Journal of Clinical Pharmacology|June 1, 1982
Comparison between atenolol and nadolol in essential hypertension at rest and on exerciseR G Wilcox, J R Hampton
British Medical Journal|August 27, 1977
Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertensionR G Wilcox, J R Mitchell
Orthopaedic Review|August 1, 1986
Unicompartmental knee arthroplastyP G Wilcox, D W Jackson
Clinics in Sports Medicine|July 1, 1987
Arthroscopic anterior cruciate ligament reconstructionP G Wilcox, D W Jackson
Thorax|December 9, 2016
β-Blockers, heart disease and COPD: current controversies and uncertaintiesJillian G Baker, Robert G Wilcox
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1978
DNA sequence of the araBAD promoter in Escherichia coli B/rL Greenfield, T Boone, G Wilcox
Vision Research|December 1, 1975
The size and shape of the pupil in lightly anaesthetized cats as a function of luminanceJ G Wilcox, H B Barlow
British Heart Journal|November 1, 1980
Importance of age in prehospital and hospital mortality of heart attacksR G Wilcox, J R Hampton
Expert Opinion on Pharmacotherapy|January 9, 2003
Thrombolytics: prospects for new agentsDaniel B McKenzie, Robert G Wilcox
Lancet (London, England)|September 19, 2003
Heart failure: treatment and ethnic originDaniel B McKenzie, Robert G Wilcox
Pageof 46

Showing results (61-70 of 454) with videos related to

Sort By:
Pageof 46
British Journal of Clinical Pharmacology|June 1, 1982
Comparison between atenolol and nadolol in essential hypertension at rest and on exerciseR G Wilcox, J R Hampton
British Medical Journal|August 27, 1977
Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertensionR G Wilcox, J R Mitchell
Orthopaedic Review|August 1, 1986
Unicompartmental knee arthroplastyP G Wilcox, D W Jackson
Clinics in Sports Medicine|July 1, 1987
Arthroscopic anterior cruciate ligament reconstructionP G Wilcox, D W Jackson
Thorax|December 9, 2016
β-Blockers, heart disease and COPD: current controversies and uncertaintiesJillian G Baker, Robert G Wilcox
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1978
DNA sequence of the araBAD promoter in Escherichia coli B/rL Greenfield, T Boone, G Wilcox
Vision Research|December 1, 1975
The size and shape of the pupil in lightly anaesthetized cats as a function of luminanceJ G Wilcox, H B Barlow
British Heart Journal|November 1, 1980
Importance of age in prehospital and hospital mortality of heart attacksR G Wilcox, J R Hampton
Expert Opinion on Pharmacotherapy|January 9, 2003
Thrombolytics: prospects for new agentsDaniel B McKenzie, Robert G Wilcox
Lancet (London, England)|September 19, 2003
Heart failure: treatment and ethnic originDaniel B McKenzie, Robert G Wilcox
Pageof 46